Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala, has obtained a go-ahead for taking a bold step to provide innovative treatment to patients suffering from COVID-19 disease.

The Trivandrum based SCTIMST is an Institution of National Importance under the Department of Science and Technology, Government of India.

Technically called “convalescent-plasma therapy”, the treatment aims at using the immune power gained by a recovered person to treat a sick person. ICMR has given approval to the SCTIMST for carrying out the novel treatment.

The therapy, like blood transfusion, harvests the antibody from a recovered patient and ingest into a sick person. Helped by the antibody, the immune system mounts robust combat on the virus.